James Crowe
Faculty Member
Last active: 3/31/2020

Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.

Zhu X, Turner HL, Lang S, McBride R, Bangaru S, Gilchuk IM, Yu W, Paulson JC, Crowe JE, Ward AB, Wilson IA
Cell Host Microbe. 2019 26 (6): 729-738.e4

PMID: 31757767 · PMCID: PMC6908751 · DOI:10.1016/j.chom.2019.10.002

Influenza virus neuraminidase (NA) is a major target for small-molecule antiviral drugs. Antibodies targeting the NA surface antigen could also inhibit virus entry and egress to provide host protection. However, our understanding of the nature and range of target epitopes is limited because of a lack of human antibody structures with influenza neuraminidase. Here, we describe crystal and cryogenic electron microscopy (cryo-EM) structures of NAs from human-infecting avian H7N9 viruses in complex with five human anti-N9 antibodies, systematically defining several antigenic sites and antibody epitope footprints. These antibodies either fully or partially block the NA active site or bind to epitopes distant from the active site while still showing neuraminidase inhibition. The inhibition of antibodies to NAs was further analyzed by glycan array and solution-based NA activity assays. Together, these structural studies provide insights into protection by anti-NA antibodies and templates for the development of NA-based influenza virus vaccines and therapeutics.

Copyright © 2019 Elsevier Inc. All rights reserved.

MeSH Terms (13)

Animals Antibodies, Monoclonal Antibodies, Neutralizing Antibodies, Viral Antiviral Agents Cryoelectron Microscopy Epitopes Humans Influenza A Virus, H7N9 Subtype Influenza Vaccines Neuraminidase Orthomyxoviridae Infections Viral Proteins

Connections (1)

This publication is referenced by other Labnodes entities: